LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.

    Pourrier, Marc / Fedida, David

    International journal of molecular sciences

    2020  Volume 21, Issue 2

    Abstract: There is a need for improved in vitro models of inherited cardiac diseases to better understand basic cellular and molecular mechanisms and advance drug development. Most of these diseases are associated with arrhythmias, as a result of mutations in ion ... ...

    Abstract There is a need for improved in vitro models of inherited cardiac diseases to better understand basic cellular and molecular mechanisms and advance drug development. Most of these diseases are associated with arrhythmias, as a result of mutations in ion channel or ion channel-modulatory proteins. Thus far, the electrophysiological phenotype of these mutations has been typically studied using transgenic animal models and heterologous expression systems. Although they have played a major role in advancing the understanding of the pathophysiology of arrhythmogenesis, more physiological and predictive preclinical models are necessary to optimize the treatment strategy for individual patients. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have generated much interest as an alternative tool to model arrhythmogenic diseases. They provide a unique opportunity to recapitulate the native-like environment required for mutated proteins to reproduce the human cellular disease phenotype. However, it is also important to recognize the limitations of this technology, specifically their fetal electrophysiological phenotype, which differentiates them from adult human myocytes. In this review, we provide an overview of the major inherited arrhythmogenic cardiac diseases modeled using hiPSC-CMs and for which the cellular disease phenotype has been somewhat characterized.
    MeSH term(s) Action Potentials ; Arrhythmias, Cardiac/congenital ; Arrhythmias, Cardiac/genetics ; Arrhythmias, Cardiac/physiopathology ; Cell Differentiation ; Cells, Cultured ; Humans ; Induced Pluripotent Stem Cells/cytology ; Induced Pluripotent Stem Cells/metabolism ; Ion Channels/genetics ; Ion Channels/metabolism ; Models, Biological ; Myocytes, Cardiac/cytology ; Myocytes, Cardiac/metabolism ; Myocytes, Cardiac/pathology
    Chemical Substances Ion Channels
    Language English
    Publishing date 2020-01-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21020657
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A generic binding pocket for small molecule

    Chan, Magnus / Sahakyan, Harutyun / Eldstrom, Jodene / Sastre, Daniel / Wang, Yundi / Dou, Ying / Pourrier, Marc / Vardanyan, Vitya / Fedida, David

    eLife

    2023  Volume 12

    Abstract: ... The ... ...

    Abstract The cardiac
    MeSH term(s) Animals ; KCNQ1 Potassium Channel/genetics ; Calmodulin/genetics ; Heart ; Heart Rate ; Immunologic Factors ; Mammals
    Chemical Substances KCNQ1 Potassium Channel ; Calmodulin ; Immunologic Factors
    Language English
    Publishing date 2023-09-14
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.87038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.

    Wei, Feng / Pourrier, Marc / Strauss, David G / Stockbridge, Norman / Pang, Li

    Toxicological sciences : an official journal of the Society of Toxicology

    2020  Volume 174, Issue 2, Page(s) 254–265

    Abstract: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great potential for personalized cardiac safety prediction, particularly for that of drug-induced proarrhythmia. However, hiPSC-CMs fire spontaneously and the variable beat rates ...

    Abstract Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great potential for personalized cardiac safety prediction, particularly for that of drug-induced proarrhythmia. However, hiPSC-CMs fire spontaneously and the variable beat rates of cardiomyocytes can be a confounding factor that interferes with data interpretation. Controlling beat rates with pacing may reduce batch and assay variations, enable evaluation of rate-dependent drug effects, and facilitate the comparison of results obtained from hiPSC-CMs with those from adult human cardiomyocytes. As electrical stimulation (E-pacing) of hiPSC-CMs has not been validated with high-throughput assays, herein, we compared the responses of hiPSC-CMs exposed with classic cardiac ion channel blockers under spontaneous beating and E-pacing conditions utilizing microelectrode array technology. We found that compared with spontaneously beating hiPSC-CMs, E-pacing: (1) reduced overall assay variabilities, (2) showed limited changes of field potential duration to pacemaker channel block, (3) revealed reverse rate dependence of multiple ion channel blockers on field potential duration, and (4) eliminated the effects of sodium channel block on depolarization spike amplitude and spike slope due to a software error in acquiring depolarization spike at cardiac pacing mode. Microelectrode array optogenetic pacing and current clamp recordings at various stimulation frequencies demonstrated rate-dependent block of sodium channels in hiPSC-CMs as reported in adult cardiomyocytes. In conclusion, pacing enabled more accurate rate- and concentration-dependent drug effect evaluations. Analyzing responses of hiPSC-CMs under both spontaneously beating and rate-controlled conditions may help better assess the effects of test compounds on cardiac electrophysiology and evaluate the value of the hiPSC-CM model.
    MeSH term(s) Action Potentials/drug effects ; Arrhythmias, Cardiac/chemically induced ; Arrhythmias, Cardiac/metabolism ; Arrhythmias, Cardiac/physiopathology ; Biological Assay ; Cardiac Pacing, Artificial ; Cardiotoxicity ; Cell Line ; Dose-Response Relationship, Drug ; Heart Rate/drug effects ; Humans ; Induced Pluripotent Stem Cells/drug effects ; Induced Pluripotent Stem Cells/metabolism ; Ion Channels/antagonists & inhibitors ; Ion Channels/metabolism ; Membrane Transport Modulators/toxicity ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Optogenetics ; Toxicity Tests
    Chemical Substances Ion Channels ; Membrane Transport Modulators
    Language English
    Publishing date 2020-02-10
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1420885-4
    ISSN 1096-0929 ; 1096-6080
    ISSN (online) 1096-0929
    ISSN 1096-6080
    DOI 10.1093/toxsci/kfaa010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Atrial selective effects of intravenously administered vernakalant in conscious beagle dogs.

    Bechard, Jeff / Pourrier, Marc

    Journal of cardiovascular pharmacology

    2011  Volume 58, Issue 1, Page(s) 49–55

    Abstract: Vernakalant is a relatively atrial-selective antiarrhythmic drug approved for the conversion of recent onset atrial fibrillation in Europe and is under regulatory review in the United States. In this study, we examined the effects of intravenously ... ...

    Abstract Vernakalant is a relatively atrial-selective antiarrhythmic drug approved for the conversion of recent onset atrial fibrillation in Europe and is under regulatory review in the United States. In this study, we examined the effects of intravenously administered vernakalant (5, 10, and 20 mg/kg) on blood pressure, heart rate, and the electrocardiogram in conscious male beagle dogs and compared them with those of orally administered dl-sotalol (32 mg/kg). Vernakalant had no consistent dose-dependent effects on the heart rate or mean arterial pressure. Although vernakalant inhibits I(Kr), it tended to decrease the QTc interval but only at the top dose and later time points. The most striking effect of vernakalant on the electrocardiogram was a dose-dependent and selective slowing of atrial conduction (P-wave duration), with no effect on ventricular conduction (QRS duration). In contrast, treatment with dl-sotalol resulted in a marked and statistically significant prolongation of PR and QTc intervals with no effect on QRS or P-wave duration, consistent with its known class II and III antiarrhythmic actions. These results provide further evidence that vernakalant is unlikely to alter ventricular refractoriness or conduction at plasma concentrations in excess of those necessary for conversion of atrial fibrillation to sinus rhythm in patients.
    MeSH term(s) Animals ; Anisoles/administration & dosage ; Anti-Arrhythmia Agents/administration & dosage ; Atrial Function/drug effects ; Atrial Function/physiology ; Blood Pressure/drug effects ; Blood Pressure/physiology ; Consciousness/drug effects ; Consciousness/physiology ; Dogs ; Dose-Response Relationship, Drug ; Heart Atria/drug effects ; Heart Rate/drug effects ; Heart Rate/physiology ; Infusions, Intravenous ; Male ; Pyrrolidines/administration & dosage
    Chemical Substances Anisoles ; Anti-Arrhythmia Agents ; Pyrrolidines ; vernakalant (9G468C8B13)
    Language English
    Publishing date 2011-07
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 391970-5
    ISSN 1533-4023 ; 0160-2446
    ISSN (online) 1533-4023
    ISSN 0160-2446
    DOI 10.1097/FJC.0b013e31821b8608
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Ranolazine improves diastolic function in spontaneously hypertensive rats.

    Williams, Sarah / Pourrier, Marc / McAfee, Donald / Lin, Shunping / Fedida, David

    American journal of physiology. Heart and circulatory physiology

    2014  Volume 306, Issue 6, Page(s) H867–81

    Abstract: Diastolic dysfunction can lead to heart failure with preserved ejection fraction, for which there is no effective therapeutic. Ranolazine has been reported to reduce diastolic dysfunction, but the specific mechanisms of action are unclear. The effect of ... ...

    Abstract Diastolic dysfunction can lead to heart failure with preserved ejection fraction, for which there is no effective therapeutic. Ranolazine has been reported to reduce diastolic dysfunction, but the specific mechanisms of action are unclear. The effect of ranolazine on diastolic function was examined in spontaneously hypertensive rats (SHRs), where left ventricular relaxation is impaired and stiffness increased. The objective of this study was to determine whether ranolazine improves diastolic function in SHRs and identify the mechanism(s) by which improvement is achieved. Specifically, to test the hypothesis that ranolazine, by inhibiting late sodium current, reduces Ca(2+) overload and promotes ventricular relaxation and reduction in diastolic stiffness, the effects of ranolazine or vehicle on heart function and the response to dobutamine challenge were evaluated in aged male SHRs and Wistar-Kyoto rats by echocardiography and pressure-volume loop analysis. The effects of ranolazine and the more specific sodium channel inhibitor tetrodotoxin were determined on the late sodium current, sarcomere length, and intracellular calcium in isolated cardiomyocytes. Ranolazine reduced the end-diastolic pressure-volume relationship slope and improved diastolic function during dobutamine challenge in the SHR. Ranolazine and tetrodotoxin also enhanced cardiomyocyte relaxation and reduced myoplasmic free Ca(2+) during diastole at high-stimulus rates in the SHR. The density of the late sodium current was elevated in SHRs. In conclusion, ranolazine was effective in reducing diastolic dysfunction in the SHR. Its mechanism of action, at least in part, is consistent with inhibition of the increased late sodium current in the SHR leading to reduced Ca(2+) overload.
    MeSH term(s) Acetanilides/pharmacology ; Acetanilides/therapeutic use ; Aging/metabolism ; Animals ; Blood Pressure/drug effects ; Blood Pressure/physiology ; Calcium/metabolism ; Cells, Cultured ; Diastole/drug effects ; Diastole/physiology ; Disease Models, Animal ; Dobutamine/pharmacology ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Hypertension/drug therapy ; Hypertension/physiopathology ; In Vitro Techniques ; Male ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Piperazines/pharmacology ; Piperazines/therapeutic use ; Ranolazine ; Rats ; Rats, Inbred SHR ; Rats, Inbred WKY ; Tetrodotoxin/pharmacology ; Ventricular Dysfunction, Left/drug therapy ; Ventricular Dysfunction, Left/physiopathology
    Chemical Substances Acetanilides ; Enzyme Inhibitors ; Piperazines ; Dobutamine (3S12J47372) ; Tetrodotoxin (4368-28-9) ; Ranolazine (A6IEZ5M406) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2014-01-24
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00704.2013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Protéines d'ancrage et mort subite cardiaque: comment et pourquoi?

    Pourrier, Marc / Nattel, Stanley

    Medecine sciences : M/S

    2004  Volume 20, Issue 4, Page(s) 437–441

    Abstract: Mutations in proteins responsible for ion transport in cardiac tissue can induce a destabilization of electrical function and provoke cardiac sudden death. Identification of a genetic anomaly in a French family that developed the syndrome of cardiac ... ...

    Title translation Anchoring proteins and cardiac sudden death: how and why?.
    Abstract Mutations in proteins responsible for ion transport in cardiac tissue can induce a destabilization of electrical function and provoke cardiac sudden death. Identification of a genetic anomaly in a French family that developed the syndrome of cardiac sudden death has revealed a crucial new element in normal cardiac electrical function : Ion channels need to be anchored to specific domains at the plasma membrane by an anchoring protein called ankyrin-B.
    MeSH term(s) Action Potentials ; Animals ; Ankyrin Repeat ; Ankyrins/chemistry ; Ankyrins/deficiency ; Ankyrins/genetics ; Ankyrins/physiology ; Arrhythmias, Cardiac/etiology ; Arrhythmias, Cardiac/genetics ; Arrhythmias, Cardiac/physiopathology ; Calcium/physiology ; Death, Sudden, Cardiac/etiology ; Electrocardiography ; Heart Conduction System/physiopathology ; Humans ; Ion Channels/genetics ; Ion Channels/physiology ; Ion Transport/genetics ; Long QT Syndrome/genetics ; Long QT Syndrome/physiopathology ; Mice ; Mice, Knockout ; Models, Biological ; Sodium/physiology
    Chemical Substances ANK2 protein, human ; Ank2 protein, mouse ; Ankyrins ; Ion Channels ; Sodium (9NEZ333N27) ; Calcium (SY7Q814VUP)
    Language French
    Publishing date 2004-04
    Publishing country France
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 632733-3
    ISSN 1958-5381 ; 0767-0974
    ISSN (online) 1958-5381
    ISSN 0767-0974
    DOI 10.1051/medsci/2004204437
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Rebuttal from Marc Pourrier, Sarah Williams, Donald McAfee, Luiz Belardinelli and David Fedida.

    Pourrier, Marc / Williams, Sarah / McAfee, Donald / Belardinelli, Luiz / Fedida, David

    The Journal of physiology

    2014  Volume 592, Issue 3, Page(s) 419

    MeSH term(s) Animals ; Heart Failure/metabolism ; Humans ; Sodium/metabolism ; Sodium Channels/metabolism
    Chemical Substances Sodium Channels ; Sodium (9NEZ333N27)
    Language English
    Publishing date 2014-02-01
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 3115-x
    ISSN 1469-7793 ; 0022-3751
    ISSN (online) 1469-7793
    ISSN 0022-3751
    DOI 10.1113/jphysiol.2013.268896
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: CrossTalk proposal: The late sodium current is an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction).

    Pourrier, Marc / Williams, Sarah / McAfee, Donald / Belardinelli, Luiz / Fedida, David

    The Journal of physiology

    2014  Volume 592, Issue 3, Page(s) 411–414

    MeSH term(s) Animals ; Diastole ; Heart Failure/etiology ; Heart Failure/metabolism ; Heart Failure/physiopathology ; Humans ; Sodium/metabolism ; Sodium Channels/metabolism ; Stroke Volume
    Chemical Substances Sodium Channels ; Sodium (9NEZ333N27)
    Language English
    Publishing date 2014-02-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 3115-x
    ISSN 1469-7793 ; 0022-3751
    ISSN (online) 1469-7793
    ISSN 0022-3751
    DOI 10.1113/jphysiol.2013.262261
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model.

    Allison, Beth / Yang, Yi / Pourrier, Marc / Gibson, John K

    Journal of cardiovascular pharmacology

    2011  Volume 57, Issue 4, Page(s) 463–468

    Abstract: A series of in vivo experiments were conducted to compare the hemodynamic actions of vernakalant (a novel, relatively atrial selective, antiarrhythmic drug) to flecainide after infusion into the peripheral vasculature. Anesthetized rats were surgically ... ...

    Abstract A series of in vivo experiments were conducted to compare the hemodynamic actions of vernakalant (a novel, relatively atrial selective, antiarrhythmic drug) to flecainide after infusion into the peripheral vasculature. Anesthetized rats were surgically prepared to have an extracorporeal perfusion circuit whereby blood in the abdominal aorta (distal to the renal arteries) was diverted to a constant flow pump and returned to the abdominal aorta at the same level allowing measurement of hindlimb vascular resistance. The effects of cumulative, ascending doses of intravenous vernakalant and flecainide on vascular resistance, after arterial pressures, and heart rate were measured. Blood samples were drawn following each dose to determine drug plasma concentrations. Vernakalant had no significant vasomotor effects on peripheral or systemic vasculature. In contrast, flecainide decreased peripheral vascular resistance (15% at 0.8 μg/mL) and systemic pressures (32% mean arterial pressure at 0.8 μg/mL) in a dose-dependent manner. At therapeutic plasma concentrations, vernakalant (1 μg/mL) had little effect on heart rate (-24 beats/min) or QRS intervals (+3.4 msec), whereas flecainide (0.8 μg/mL) significantly decreased heart rate (55 beats/min) and increased QRS intervals (9.9 msec). In conclusion, vernakalant did not have negative hemodynamic effects at therapeutic plasma concentrations in a rat hindlimb perfusion model.
    MeSH term(s) Animals ; Anisoles/administration & dosage ; Anisoles/pharmacokinetics ; Anisoles/pharmacology ; Anti-Arrhythmia Agents/administration & dosage ; Anti-Arrhythmia Agents/pharmacokinetics ; Anti-Arrhythmia Agents/pharmacology ; Aorta, Abdominal/drug effects ; Aorta, Abdominal/metabolism ; Blood Pressure/drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Flecainide/administration & dosage ; Flecainide/pharmacokinetics ; Flecainide/pharmacology ; Hindlimb ; Male ; Pyrrolidines/administration & dosage ; Pyrrolidines/pharmacokinetics ; Pyrrolidines/pharmacology ; Rats ; Rats, Sprague-Dawley ; Vascular Resistance/drug effects
    Chemical Substances Anisoles ; Anti-Arrhythmia Agents ; Pyrrolidines ; vernakalant (9G468C8B13) ; Flecainide (K94FTS1806)
    Language English
    Publishing date 2011-04
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 391970-5
    ISSN 1533-4023 ; 0160-2446
    ISSN (online) 1533-4023
    ISSN 0160-2446
    DOI 10.1097/FJC.0b013e318210276b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.

    Burashnikov, Alexander / Pourrier, Marc / Gibson, John K / Lynch, Joseph J / Antzelevitch, Charles

    Circulation. Arrhythmia and electrophysiology

    2012  Volume 5, Issue 2, Page(s) 400–408

    Abstract: Background: Several clinical trials have shown that vernakalant is effective in terminating recent onset atrial fibrillation (AF). The electrophysiological actions of vernakalant are not fully understood.: Methods and results: Here we report the ... ...

    Abstract Background: Several clinical trials have shown that vernakalant is effective in terminating recent onset atrial fibrillation (AF). The electrophysiological actions of vernakalant are not fully understood.
    Methods and results: Here we report the results of a blinded study comparing the in vitro canine atrial electrophysiological effects of vernakalant, ranolazine, and dl-sotalol. Action potential durations (APD(50,75,90)), effective refractory period (ERP), post repolarization refractoriness (PRR), maximum rate of rise of the action potential (AP) upstroke (V(max)), diastolic threshold of excitation (DTE), conduction time (CT), and the shortest S(1)-S(1) permitting 1:1 activation (S(1)-S(1)) were measured using standard stimulation and microelectrode recording techniques in isolated normal, non-remodeled canine arterially perfused left atrial preparations. Vernakalant caused variable but slight prolongation of APD(90) (P=not significant), but significant prolongation of APD(50) at 30 μmol/L and rapid rates. In contrast, ranolazine and dl-sotalol produced consistent concentration- and reverse rate-dependent prolongation of APD(90). Vernakalant and ranolazine caused rate-dependent, whereas dl-sotalol caused reverse rate-dependent, prolongation of ERP. Significant rate-dependent PRR developed with vernakalant and ranolazine, but not with dl-sotalol. Other sodium channel-mediated parameters (ie, V(max), CT, DTE, and S(1)-S(1)) also were depressed significantly by vernakalant and ranolazine, but not by dl-sotalol. Only vernakalant elevated AP plateau voltage, consistent with blockade of ultrarapid delayed rectified potassium current and transient outward potassium current.
    Conclusions: In isolated canine left atria, the effects of vernakalant and ranolazine were characterized by use-dependent inhibition of sodium channel-mediated parameters, and those of dl-sotalol by reverse rate-dependent prolongation of APD(90) and ERP. This suggests that during the rapid activation rates of AF, the I(Na) blocking action of the mixed ion channel blocker vernakalant takes prominence. This mechanism may explain vernakalant's anti-AF efficacy.
    MeSH term(s) Acetanilides/pharmacology ; Action Potentials/drug effects ; Action Potentials/physiology ; Animals ; Anisoles/pharmacology ; Anti-Arrhythmia Agents/pharmacology ; Dogs ; Female ; Heart Atria/drug effects ; In Vitro Techniques ; Male ; Models, Animal ; Piperazines/pharmacology ; Pyrrolidines/pharmacology ; Ranolazine ; Refractory Period, Electrophysiological/drug effects ; Refractory Period, Electrophysiological/physiology ; Sodium Channel Blockers/pharmacology ; Sodium Channels/drug effects ; Sodium Channels/physiology ; Sotalol/pharmacology ; Time Factors
    Chemical Substances Acetanilides ; Anisoles ; Anti-Arrhythmia Agents ; Piperazines ; Pyrrolidines ; Sodium Channel Blockers ; Sodium Channels ; vernakalant (9G468C8B13) ; Sotalol (A6D97U294I) ; Ranolazine (A6IEZ5M406)
    Language English
    Publishing date 2012-02-09
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2426129-4
    ISSN 1941-3084 ; 1941-3149
    ISSN (online) 1941-3084
    ISSN 1941-3149
    DOI 10.1161/CIRCEP.111.968305
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top